Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 2120

1.

Update on aspirin in the treatment and prevention of cardiovascular disease.

Hennekens CH.

Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700. Review.

2.

Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, Sudlow C, Henderson R, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. Review.

4.

The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.

Hennekens CH, Schneider WR.

Expert Rev Cardiovasc Ther. 2008 Jan;6(1):95-107. Review.

PMID:
18095910
5.
6.

Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.

Mehta SR, Yusuf S.

J Am Coll Cardiol. 2003 Feb 19;41(4 Suppl S):79S-88S. Review.

PMID:
12644345
7.
8.
9.

Role of antiplatelet drugs in the prevention of cardiovascular events.

Tendera M, Wojakowski W.

Thromb Res. 2003 Jun 15;110(5-6):355-9. Review.

PMID:
14592562
10.

Prevention of cardiovascular disease: risks and benefits of aspirin.

Buring JE, Hennekens CH.

J Gen Intern Med. 1990 Sep-Oct;5(5 Suppl):S54-7. Review.

PMID:
2231066
11.

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Antithrombotic Trialists' Collaboration.

BMJ. 2002 Jan 12;324(7329):71-86. Erratum in: BMJ 2002 Jan 19;324(7330):141.

12.

An update on aspirin in the primary prevention of cardiovascular disease.

Eidelman RS, Hebert PR, Weisman SM, Hennekens CH.

Arch Intern Med. 2003 Sep 22;163(17):2006-10.

PMID:
14504112
13.

Antiplatelet therapy in the prevention of ischaemic stroke.

Verry M, Panak E, Cazenave JP.

Nouv Rev Fr Hematol. 1994 Jun;36(3):213-28. Review.

PMID:
7971242
14.

Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.

Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S; Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial.

Circulation. 2004 Sep 7;110(10):1202-8. Epub 2004 Aug 16.

15.

Antiplatelet drugs.

Hankey GJ, Eikelboom JW.

Med J Aust. 2003 Jun 2;178(11):568-74.

PMID:
12765506
16.

The role of aspirin in cardiovascular diseases--forgotten benefits?

Williams A, Hennekens CH.

Expert Opin Pharmacother. 2004 Jan;5(1):109-15. Review.

PMID:
14680440
17.
18.

New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.

Spinler SA, Hilleman DE, Cheng JW, Howard PA, Mauro VF, Lopez LM, Munger MA, Gardner SF, Nappi JM.

Ann Pharmacother. 2001 May;35(5):589-617. Review.

PMID:
11346067
19.

Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus.

Colwell JA.

Am J Cardiovasc Drugs. 2004;4(2):87-106. Review.

PMID:
15049721
20.

Update on aspirin in the treatment and prevention of cardiovascular disease.

Hennekens CH.

Am Heart J. 1999 Apr;137(4 Pt 2):S9-S13. Review.

PMID:
10097241
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk